Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 years old
- People with a leg circulation problem rated at Rutherford category 3, 4, or 5 — meaning moderate to severe symptoms such as leg pain at rest or small wounds that won't heal (confirm with trial site)
- People who have a significant narrowing (70% or more) or a blockage in an artery below the knee, either new or previously treated, where blood flow beyond the blockage is still open
- People whose affected artery measures between 2 mm and 4 mm in diameter
- People who have given written consent, understand the purpose of the trial, and agree to attend all required check-ups and follow-up visits
Who may not be able to join:
- People whose kidneys are not filtering blood well enough (creatinine clearance below 30 mL/min)
- People who have a sudden, new blockage or blood clot in the artery being treated
- People who are already scheduled to have a limb amputation on the leg being treated
- People who are completely confined to bed and unable to walk at all
- People who have had a clot-dissolving treatment or surgery on the affected leg within the 6 weeks before joining
- People whose life expectancy is estimated to be less than 5 years
- People whose total length of complete blockages in the target artery adds up to more than 150 mm
- People who have a blockage inside a previously placed stent in the target area, or whose blockage is within 20 mm of an existing stent
- People who have had a stroke in the 90 days before joining
- People with a known allergy to contrast dye (used in imaging), blood-thinning medications, or clot-dissolving medications
- People with a bleeding disorder that cannot be corrected
- People where a complete blockage in a specific section of the artery behind the knee (the P3 segment of the popliteal artery) prevents doctors from identifying blood flow into the treated area (confirm with trial site)
- People who are pregnant or breastfeeding
- People whose blockage cannot be crossed with a guidewire during the procedure (confirm with trial site)
- People who are currently participating in another clinical trial of a medical device or drug
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhuang Baixi, Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phone: 010-62835122
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Patency
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.